Rheumatology NewsILD Subtypes in Rheumatoid Arthritis Carry Different Risk Factor ProfilesSeptember 27, 2024Rheumatoid Arthritis
Rheumatology NewsFirst Hike of Medicare Funding for Residencies in 25 Years Aims to Help ShortagesSeptember 27, 2024Business of Medicine
Rheumatology NewsDirect-to-Consumer Testing’s Expansion to Rheumatology Has Benefits but Potential RisksSeptember 27, 2024Business of MedicineRheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
Rheumatology NewsFDA’s Stricter Regulation of Lab-Developed Tests Faces Lawsuits and Lingering ConcernsSeptember 24, 2024Business of Medicine
Rheumatology NewsBimekizumab Gains FDA Approval for Psoriatic Arthritis, Axial SpondyloarthritisSeptember 24, 2024Psoriatic ArthritisSpondyloarthropathies
Rheumatology NewsMuscle Relaxants for Chronic Pain: Where Is the Greatest Evidence?September 23, 2024Pain
Rheumatology NewsPatient Navigators in Rheumatology Set to Expand in Importance, Scope With New Medicare CodesSeptember 23, 2024Lupus & Connective Tissue DiseasesBusiness of Medicine
Rheumatology NewsTrial Looks at Early Use of Mycophenolate to Reduce Flares, NephritisSeptember 23, 2024Lupus & Connective Tissue Diseases
Rheumatology NewsHypnosis May Offer Relief During Sharp Debridement of Skin UlcersSeptember 23, 2024Lupus & Connective Tissue DiseasesPain
Rheumatology NewsIdentifying Drug-Induced Rashes in Skin of Color: Heightened Awareness Can Accelerate DiagnosisSeptember 23, 2024Diversity in Medicine
Rheumatology NewsFDA Initiative Aims to Improve Diversity in Clinical TrialsSeptember 23, 2024Diversity in Medicine
Rheumatology NewsAre You Using the Correct Medication or a Look-Alike?September 20, 2024Business of Medicine
Rheumatology NewsBenralizumab Now FDA Approved to Treat EGPA VasculitisSeptember 19, 2024Lupus & Connective Tissue DiseasesVasculitis
Rheumatology NewsRheumatology RCTs Have Lower Representation of Women as AuthorsSeptember 18, 2024Business of Medicine
